Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Shilpa Medicare's score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Shilpa Medicare reported total carbon emissions of approximately 24,892,210 kg CO2e, comprising about 3,690,310 kg CO2e from Scope 1 and about 20,389,900 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company recorded emissions of about 16,220,940 kg CO2e, with Scope 1 emissions at approximately 1,523,280 kg CO2e and Scope 2 emissions at about 14,691,660 kg CO2e. Shilpa Medicare has set ambitious climate commitments, aiming to achieve 100% renewable energy usage by 2030 and to become a net-zero carbon company by 2050. These targets encompass all scopes of emissions, reflecting a long-term strategy to lead the energy transition. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Overall, Shilpa Medicare's commitment to sustainability and carbon reduction aligns with industry standards and reflects a proactive approach to climate change mitigation.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,523,280 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,691,660 | 00,000,000 | 00,000,000 |
| Scope 3 | 877,770 | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shilpa Medicare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

